The MIB-1 tumor proliferation index in adult renal epithelial tumors with granular cytoplasm: Biologic implications and differential diagnostic potential

Modern Pathology

Volumn 11, Issue 11, 1998, Pages 1115-1121

  Tickoo, Satish K ^a   Amin, Mahul B ^a,b   Linden, Michael D ^a   Zarbo, Richard J ^a  

^a HENRY FORD HOSPITAL   (United States)

^b EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

Chromophobe renal cell carcinoma; Eosinophilic variant of clear cell renal cell carcinoma; MIB 1; Papillary renal cell carcinoma; Renal oncocytoma; Renal cell carcinoma; Tumor proliferation index

Indexed keywords

KI 67 ANTIGEN; MONOCLONAL ANTIBODY KI 67;

ARTICLE; CYTOPLASM; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; ONCOCYTOMA; PRIORITY JOURNAL;

ADENOCARCINOMA; ADENOMA, OXYPHILIC; ADULT; ANTIBODIES, MONOCLONAL; CARCINOMA, RENAL CELL; CELL DIVISION; CYTOPLASM; CYTOPLASMIC GRANULES; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; KIDNEY; KIDNEY NEOPLASMS; MITOTIC INDEX; NEOPLASMS, GLANDULAR AND EPITHELIAL;

EID: 0031788141     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Amin MB, Corless CL, Renshaw AA, Tickoo SK, Kubus J, Schultz DS. Papillary (chromophil) renal-cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases. Am J Surg Pathol 1997;21:621-35.
2. Amin MB, Crotty TB, Tickoo SK, Farrow GM. Renal oncocytoma: a reappraisal of morphologic features with clinicopathologic findings in 80 cases. Am J Surg Pathol 1997;21:1-12.
3. Amin MB, Varma MD, Tickoo SK, Ro JY. Collecting duct carcinoma of the kidney: a review. Adv Anat Pathol 1997;4: 85-94.
4. Akhtar M, Kardar H, Linjawi T, McClintock J, Ali MA. Chromophobe cell carcinoma of the kidney: a clinicopathologic study of 21 cases. Am J Surg Pathol 1995;19:1245-56.
5. Bonsib S, Lager D. Chromophobe cell carcinoma: analysis of five cases. Am J Surg Pathol 1990;14:260-7.
6. Crotty TB, Farrow GM, Lieber MM. Chromophobe cell renal carcinoma: clinicopathological features of 50 cases. J Urol 1995;154:964-7.
7. Davis CJ Jr, Sesterhenn IA, Mostofi FK, Ho CK. Renal oncocytoma: clinicopathological study of 166 patients. J Urogenital Pathol 1991;1:41-52.
8. Durham JR, Keohane M, Amin MB. Chromophobe renal-cell carcinoma. Adv Anat Pathol 1996;3:336-42.
9. Hamed G, Perez-Ordonez B, Russo P, Gaudin PB, Reuter VE. Chromophobe renal-cell carcinoma: a clinicopathological study of 51 cases [abstract]. Mod Pathol 1996;9:72A.
10. Lieber MM, Tomera KM, Farrow GM. Renal oncocytoma. J Urol 1981;125:481-5.
11. Murphy WM, Beckwith JB, Farrow GM. Tumors of kidney, bladder, and related urinary structures. In: Atlas of tumor pathology. 3rd series. Fascicle 11. Washington, DC: Armed Forces Institute of Pathology; 1994. p. 1-192.
12. Thoenes W, Störkel S, Rumpelt HJ, Moll R, Baum HP, Werner S. Chromophobe cell renal carcinoma and its variants: a report on 32 cases. J Pathol 1988;155:277-87.
13. Weiss LM, Gelb AB, Medeiros LJ. Adult renal epithelial neoplasms. Am J Clin Pathol 1995;103:624-35.
14. Perez Ordonez B, Hamed G, Campbell S, Erlandson RA, Russo P, Gaudin PB, et al. Renal oncocytoma: a clinicopathologic study of 70 cases. Am J Surg Pathol 1997;21:871-83.
15. Tickoo SK, Amin MB, Zarbo RJ. Colloidal iron staining in renal epithelial neoplasms including chromophobe renal-cell carcinoma: emphasis on technique and patterns of staining. Am J Surg Pathol 1998;22:419-24.
16. Mackay B, Ordóñez NG, Khoursand J, Bennington JL. The ultrastructure and immunocytochemistry of renal-cell carcinoma. Ultrastruct Pathol 1987;11:483-502.
17. Bonsib SM, Bromley C. Immunocytochemical analysis of band 3 protein in renal-cell carcinoma, nephroblastoma, and oncocytoma. Arch Pathol Lab Med 1994;118:702-4.
18. DeLong WH, Sakr W, Grignon DJ. Chromophobe renal-cell carcinoma: a comparative histochemical and immunohistochemical study. J Urol Pathol 1996;4:1-8.
19. Tickoo SK, Amin MB, Linden MD, Lee MW, Zarbo RJ. Antimitochondrial antibody (113-1) in the differential diagnosis of granular renal-cell tumors. Am J Surg Pathol 1997;21:922-30.
20. Bugert P, Kovacs G. Molecular differential diagnosis of renal-cell carcinomas by microsatellite analysis. Am J Pathol 1996; 149:2081-8.
21. Kovacs G. Molecular differential pathology of renal-cell tumors. Histopathology 1993;22:1-8.
22. Kovacs G. The value of molecular genetic analysis in the diagnosis and prognosis of renal-cell tumors. World J Urol 1994;12:64-8.
23. Speicher MR, Schoell B, duManoir S, Schröck E, Ried T, Cremer T, et al. Specific loss of chromosomes 1, 2, 6, 10, 13, 17, and 21 in chromophobe renal-cell carcinomas revealed by comparative genomic hybridization. Am J Pathol 1994; 145:356-64.
24. Steiner G, Sidransky D. Molecular differential diagnosis of renal carcinoma: from microscopes to microsatellites. Am J Pathol 1996;149:1791-5.
25. van den Berg E, van der Hout AH, Oosterhuis JW, Störkel S, Dijkhuizen T, Dam A, et al. Cytogenetic analysis of epithelial renal-cell tumors: relationship with a new histopathological classification. Int J Cancer 1993;55:223-7.
26. Eble JN, Hull MT. Morphologic features of renal oncocytoma: a light and electron microscopic study. Hum Pathol 1984;15:1054-61.
27. Herrera GA, Turbat-Herrera EA. The role of ultrastructural pathology in the diagnosis of epithelial and unusual renal tumors. Ultrastruct Pathol 1996;20:7-26.
28. Simmons JL, Jaqua RA, Peterson KG. Ultrastructural evaluation of renal-cell oncocytoma. Ultrastruct Pathol 1996;20: 395-397.
29. Skinnider BF, Jones EC. Renal oncocytoma and chromophobe carcinoma: a comparative immunohistochemical and ultrastructural analysis [abstract]. Mod Pathol 1997;10:91A.
30. Tickoo SK, Lee MW, Eble JN, Amin MB. Discriminant value of ultrastructural features of mitochondria and microvesicles in the differential diagnosis of renal tumors with granular cytoplasm [abstract]. Mod Pathol 1997;10:91A.
31. Thoenes W, Störkel S, Rumpelt HJ. Human chromophobe cell renal carcinoma. Virchows Arch B Cell Pathol Incl Mol Pathol 1985;48:207-17.
32. Hermanek P, Schrott KM. Evaluation of the new tumor, nodes, and metastases classification of renal-cell carcinoma. J Urol 1990;144:238-42.
33. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal-cell carcinomas. Am J Surg Pathol 1982;6:655-63.
34. Tamboli P, Amin MB, Schultz DS, Linden MD, Kubus J. Comparative analysis of the nuclear proliferative index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma. Mod Pathol 1996;9:1015-9.
35. Mulder AH, van Hootegem JC, Sylvester R, ten Kate FJ, Kurth KH, Ooms EC, et al. Prognostic factors in bladder carcinoma: histologic parameters and expression of a cell cycle-related nuclear antigen (Ki-67). J Pathol 1992;166:37-43.
36. Sahin AA, Ro J, Ro JY, Blick MB, el-Naggar AK, Ordóñez NG, et al. Ki-67 immunostaining in node negative stage I/II breast cancer. Cancer 1991;68:549-57.
37. Wintzer HO, Zipfel I, Schulte-Moning J, Hellerich U, von Kleist S. Ki-67 immunostaining in human breast tumors and its relationship to prognosis. Cancer 1991;67:421-8.
38. Tungekar MF, Gatter KG, Dunnill MS, Mason DY. K-67 immunostaining and survival in operable lung cancers. Histopathology 1991;19:545-50.
39. Gerdes J. Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluation in human malignancies. Semin Cancer Biol 1990;1:199-200.
40. de Riese WTW, Crabtree WN, Allhoff EP, Werner M, Liedke S, Lenis G, et al. Prognostic significance of Ki-67 immunostaining in nonmetastatic renal-cell carcinoma. J Clin Oncol 1993; 11:1804-8.
41. de Peralta-Venturina MN, Amin MB, Keoleian CM, Schultz DS, Kubus JJ, Linden MD, et al. Papillary renal-cell carcinoma: assessment of proliferative activity using PCNA and MIB-1 (Ki-67) and correlation with clinicopathological findings. Appl Immunohistochem 1994;2:241-7.
42. Tannapfel A, Hahn HA, Katalinic A, Fietkau RJ, Kuhn R, Wittekind CW. Prognostic value of ploidy and proliferation markers in renal-cell carcinoma. Cancer 1996;77:164-71.
43. Todd D, Yang G, Brown RW, Cao J, D'Agati V, Thompson TS, et al. Apoptosis in renal-cell carcinoma: detection by in situ end-labeling of fragmented DNA and correlation with other prognostic factors. Hum Pathol 1996;27:1012-7.
44. McCormick D, Chong H, Hobbs C, Datta C, Hall PA. Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody, MIB-1. Histopathology 1993;22:355-60.
45. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody, Ki-67. J Immunol 1984;133:1710-5.
46. Gerdes J, Dallenbach F, Lennert K. Growth fractions in non-Hodgkin's lymphoma (NHL) as determined in situ with the monoclonal antibody Ki-67. Hematol Oncol 1984;2:365-71.
47. Stenfert-Kroese MC, Rutgers DH, Wils IS, van Unnik JA, Roholl PJ. The relevance of DNA index and proliferation rate in the grading of benign and malignant soft tissue tumors. Cancer 1990;65:1782-8.
48. Deshmukh P, Ramsey L, Garewal HS. Ki-67 labeling index is more reliable measure of solid tumor proliferation activity than tritiated thymidine labeling. Am J Clin Pathol 1990;94: 192-5.
49. Amin M, Tambeli P, Javidan J, Stricker H, Peabody J, Deshpande A, et al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms (REN) [abstract]. Mod Pathol 1998;11:75A.
50. Schienfeld AG, Campbell S, Gaudin PB, Bryant DA, Reuter VE. Conventional (clear cell) renal cell carcinoma: a clinicopathologic study of 155 consecutive cases [abstract]. Mod Pathol 1998;11:94A.